Objective | Obtain validated hits that can inhibit leukemic cell growth by targeting Brg1 ATPase activity |
---|---|
Principal Investigator | Julie Lessard |
Competitive Advantages
New AML models – CCCs*
Objective | Obtain validated hits that can inhibit leukemic cell growth by targeting Brg1 ATPase activity |
---|---|
Principal Investigator | Julie Lessard |
New AML models – CCCs*
© 2008-2021 IRICoR